BamSEC and AlphaSense Join Forces
Learn More

Adaptive Biotechnologies Corporation

NASDAQ: ADPT    
Share price (12/20/24): $6.39    
Market cap (12/20/24): $943 million

Material Contracts Filter

EX-10.1
from 8-K 2 pages April 1, 2024 Kyle Piskel
12/34/56
EX-10
from 10-K 5 pages Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy Last Updated January 26, 2023
12/34/56
EX-10.1
from 10-Q 15 pages Adaptive Biotechnologies Corporation Performance Units Agreement
12/34/56
EX-10.17
from 10-K 17 pages Adaptive Biotechnologies Corporation Restricted Stock Units Agreement
12/34/56
EX-10.16
from 10-K 17 pages Adaptive Biotechnologies Corporation Stock Option Agreement
12/34/56
EX-10.12
from 10-K 4 pages Adaptive Biotechnologies Corporation Non-Employee Director Compensation Policy Last Updated February 14, 2021
12/34/56
EX-10.1
from 10-Q 7 pages Adaptive Biotechnologies Corporation Executive Severance Agreement
12/34/56
EX-10.3
from 10-Q 24 pages Ivd Test Kit Development and Supply Agreement
12/34/56
EX-10.12
from 10-Q 65 pages Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 49 pages Lease Agreement
12/34/56
EX-10.1
from 8-K 15 pages Sixth Amendment to Lease
12/34/56
EX-10.17
from S-1/A 25 pages Adaptive Biotechnologies Corporation 2019 Employee Stock Purchase Plan
12/34/56
EX-10.16
from S-1/A 44 pages Adaptive Biotechnologies Corporation 2019 Equity Incentive Plan
12/34/56
EX-10.14
from S-1/A 4 pages Adaptive Biotechnologies Corporation Outside Director Compensation Policy Adopted and Approved June 10, 2019
12/34/56
EX-10.3
from S-1/A 10 pages Master Terms and Conditions of Sale
12/34/56
EX-10.18
from S-1 112 pages Lease Agreement
12/34/56
EX-10.15
from S-1 59 pages Adaptive Biotechnologies Corporation 2009 Equity Incentive Plan
12/34/56
EX-10.13
from S-1 15 pages Adaptive Biotechnologies Corporation Indemnification Agreement
12/34/56
EX-10.12
from S-1 5 pages This Letter Agreement (This “Agreement”) Confirms the Terms of Your Severance Rights in Connection With Your Employment With Adaptive Biotechnologies Corporation, a Washington Corporation (The “Company”), and Supplements That Certain Letter Agreement Regarding Your Employment With the Company Dated on or About May 1, 2019 (The “Employment Agreement”). Capitalized Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed to Them in the Employment Agreement. 1. Severance as Further Detailed in Your Employment Agreement, Your Employment With the Company Is “At Will”; It Is for No Specified Term, and May Be Terminated by You or the Company at Any Time, With or Without Cause or Advance Notice
12/34/56
EX-10.11
from S-1 5 pages This Letter Agreement (This “Agreement”) Confirms the Terms of Your Severance Rights in Connection With Your Employment With Adaptive Biotechnologies Corporation, a Washington Corporation (The “Company”), and Supplements That Certain Letter Agreement Regarding Your Employment With the Company Dated on or About the Date Hereof (The “Employment Offer”). Capitalized Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed to Them in the Employment Offer. 1. Severance as Further Detailed in Your Employment Offer, Your Employment With the Company Is “At Will”; It Is for No Specified Term, and May Be Terminated by You or the Company at Any Time, With or Without Cause or Advance Notice
12/34/56